Bionano Genomics Inc. (BNGO)
3.95
-0.05 (-1.25%)
At close: Mar 04, 2025, 3:59 PM
3.93
-0.51%
After-hours: Mar 04, 2025, 05:55 PM EST
Bionano Genomics Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
| Net Income | -232.49M | -132.6M | -72.44M | -41.11M | -29.82M | -18.5M | -23.37M | -18.85M |
| Depreciation & Amortization | 13.91M | 9.84M | 3.37M | 1.48M | 1.13M | 1.32M | 1.5M | 1.12M |
| Stock-Based Compensation | 15.18M | 22.42M | 9.72M | 1.55M | 1.35M | 1.31M | 382.83K | 130.64K |
| Other Working Capital | -6.33M | -3.96M | 1.99M | 483.49K | -318.96K | -95.39K | 647.32K | -770.34K |
| Other Non-Cash Items | 92.99M | 2.35M | 848K | 1.26M | 883.27K | 750.47K | 96.58K | 73.9K |
| Deferred Income Tax | n/a | 1.76M | -5.78M | 1.93M | 1.9M | -2.46M | 479.01K | -3.01M |
| Change in Working Capital | -14.77M | -28.59M | -7.65M | -3.44M | -4.97M | -2.37M | 85.1K | -2.96M |
| Operating Cash Flow | -125.18M | -124.82M | -71.93M | -38.31M | -29.53M | -19.94M | -20.82M | -23.5M |
| Capital Expenditures | -1.69M | -3.3M | -1.46M | n/a | -61.06K | -331.72K | -1.02M | -1.35M |
| Acquisitions | 96K | -31.34M | -49.09M | -2.45M | n/a | n/a | n/a | n/a |
| Purchase of Investments | -111.26M | -84.19M | -313.39M | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | 137.02M | 200.89M | 86.48M | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | 720K | -607K | n/a | n/a | n/a | n/a | n/a |
| Investing Cash Flow | 24.16M | 82.77M | -278.06M | -2.45M | -61.06K | -331.72K | -1.02M | -1.35M |
| Debt Repayment | -47K | -36K | -15.01M | -4.72M | 9.82M | 16.38M | n/a | 1.89M |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 56.16M | -85K | 8.4M | 26.69M | 1M | 3.5K | 17.61M | 23.54M |
| Financial Cash Flow | 113.81M | 23.01M | 336.11M | 61.9M | 30.38M | 35.78M | 17.61M | 25.43M |
| Net Cash Flow | 12.86M | -19.08M | -13.88M | 21.14M | 788.64K | 15.5M | -4.23M | 584.85K |
| Free Cash Flow | -126.87M | -128.12M | -73.39M | -38.31M | -29.59M | -20.28M | -21.84M | -24.85M |